GLENMARK PHARMACEUTICALS LTD.GLENMARK PHARMACEUTICALS LTD.GLENMARK PHARMACEUTICALS LTD.

GLENMARK PHARMACEUTICALS LTD.

No trades
See on Supercharts
Market capitalization
‪296.73 B‬INR
−25.20INR
‪2.97 B‬INR
‪129.90 B‬INR
‪138.38 M‬
Beta (1Y)
1.35

About GLENMARK PHARMACEUTICALS LTD.

CEO
Glenn Mario Saldanha
Headquarters
Mumbai
Employees (FY)
‪14.97 K‬
Founded
1977
ISIN
INE935A01035
FIGI
BBG000BJ3V03
Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. It operates through the India, North America, Latin America, Europe, and Rest of the World geographical segments. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GLENMARK is 1 044.00 INR — it has decreased by 0.03% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange GLENMARK PHARMACEUTICALS LTD. stocks are traded under the ticker GLENMARK.
GLENMARK PHARMACEUTICALS LTD. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for GLENMARK PHARMACEUTICALS LTD. has a max estimate of 1 266.00 INR and a min estimate of 570.00 INR.
GLENMARK earnings for the last quarter are 6.90 INR whereas the estimation was 11.16 INR which accounts for −38.17% surprise. Estimated earnings for the next quarter are 12.08 INR. See more details about GLENMARK PHARMACEUTICALS LTD. earnings.
GLENMARK PHARMACEUTICALS LTD. revenue for the last quarter amounts to ‪32.07 B‬ INR despite the estimated figure of ‪35.83 B‬ INR. In the next quarter revenue is expected to reach ‪35.01 B‬ INR.
Yes, you can track GLENMARK PHARMACEUTICALS LTD. financials in yearly and quarterly reports right on TradingView.
Like other stocks, GLENMARK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLENMARK PHARMACEUTICALS LTD. stock right from TradingView charts — choose your broker and connect to your account.
GLENMARK reached its all-time high on Aug 21, 2015 with the price of 1 261.95 INR, and its all-time low was 19.65 INR and was reached on Nov 5, 2003.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪14.97 K‬ employees. See our rating of the largest employees — is GLENMARK PHARMACEUTICALS LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLENMARK PHARMACEUTICALS LTD. EBITDA is ‪14.90 B‬ INR, and current EBITDA margin is 17.89%. See more stats in GLENMARK PHARMACEUTICALS LTD. financial statements.